Evidence map›Paper›PMID 42381444›Full record

ArticleJournal of diabetes science and technology2026

Diabetes Technologist: Optimal Use of Technology in Everyday Practice.

Lutz Heinemann, Jonas Laaser

Abstract readEditorial
In one paragraph

Article in Journal of diabetes science and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lutz HeinemannScience-Consulting in Diabetes GmbH, Düsseldorf, Germany.ORCID 0000-0003-2493-1304
Jonas LaaserDiabetes and Family Doctor Center Hamburg-Süd, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes technology (DT) is a major pillar of modern diabetes therapy that enables many people with diabetes (PwD) to achieve optimal glucose control. Diabetes technology is also advancing at a high speed, which brings new challenges. In addition, the number of PwD continues to rise, while the number of health care professionals is declining. The use of DT requires a lot of specialized knowledge, including the handling and troubleshooting of various technological systems. This means that a considerable amount of effort is required to stay up to date with all relevant products. Additional training of certified diabetes specialists and diabetes counselors to become "diabetes technologists" can be an answer to this job description. Several aspects associated with such a position are discussed in this article.

Indexed as

Diabetes MellitusBlood GlucoseBlood Glucose Self-MonitoringContinuous Glucose MonitoringDigital HealthGlycemic ControlHumansInsulin Infusion SystemsBlood GlucoseAIDCGMdiabetes technologydiabetes therapy

Identifiers

PMID42381444
PMCPMC12528056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.